• SMC approves funding for six new therapies on the NHS pharmatimes
    July 10, 2018
    The Scottish Medicines Consortium has approved NHS funding for six new therapies, offering patients new options for leukaemia, epilepsy, lung cancer, plaque psoriasis, and carcinoid syndrome-related diarrhea.
PharmaSources Customer Service